These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 12496080)

  • 1. Conformational partitioning of the fusion peptide of HIV-1 gp41 and its structural analogs in bilayer membranes.
    Maddox MW; Longo ML
    Biophys J; 2002 Dec; 83(6):3088-96. PubMed ID: 12496080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fully hydrophobic HIV gp41 adopts a hemifusion-like conformation in phospholipid bilayers.
    Lee M; Morgan CA; Hong M
    J Biol Chem; 2019 Oct; 294(40):14732-14744. PubMed ID: 31409642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the fusion peptide and membrane-proximal domain in HIV-1 envelope glycoprotein-mediated membrane fusion.
    Dimitrov AS; Rawat SS; Jiang S; Blumenthal R
    Biochemistry; 2003 Dec; 42(48):14150-8. PubMed ID: 14640682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The polar region consecutive to the HIV fusion peptide participates in membrane fusion.
    Peisajovich SG; Epand RF; Pritsker M; Shai Y; Epand RM
    Biochemistry; 2000 Feb; 39(7):1826-33. PubMed ID: 10677233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane interactions of the synthetic N-terminal peptide of HIV-1 gp41 and its structural analogs.
    Mobley PW; Waring AJ; Sherman MA; Gordon LM
    Biochim Biophys Acta; 1999 Apr; 1418(1):1-18. PubMed ID: 10209206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The amino-terminal peptide of HIV-1 glycoprotein 41 interacts with human erythrocyte membranes: peptide conformation, orientation and aggregation.
    Gordon LM; Curtain CC; Zhong YC; Kirkpatrick A; Mobley PW; Waring AJ
    Biochim Biophys Acta; 1992 Aug; 1139(4):257-74. PubMed ID: 1355364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hydrophobic internal region of bovine prion protein shares structural and functional properties with HIV type 1 fusion peptide.
    Sáez-Cirión A; Nieva JL; Gallaher WR
    AIDS Res Hum Retroviruses; 2003 Nov; 19(11):969-78. PubMed ID: 14678604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatty acids can substitute the HIV fusion peptide in lipid merging and fusion: an analogy between viral and palmitoylated eukaryotic fusion proteins.
    Lev N; Shai Y
    J Mol Biol; 2007 Nov; 374(1):220-30. PubMed ID: 17919659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The helix-to-sheet transition of an HIV-1 fusion peptide derivative changes the mechanical properties of lipid bilayer membranes.
    Heller WT; Zolnierczuk PA
    Biochim Biophys Acta Biomembr; 2019 Mar; 1861(3):565-572. PubMed ID: 30550881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular dynamics simulation of HIV-1 fusion domain-membrane complexes: Insight into the N-terminal gp41 fusion mechanism.
    Promsri S; Ullmann GM; Hannongbua S
    Biophys Chem; 2012; 170():9-16. PubMed ID: 22892124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational mapping of the N-terminal peptide of HIV-1 gp41 in membrane environments using (13)C-enhanced Fourier transform infrared spectroscopy.
    Gordon LM; Mobley PW; Pilpa R; Sherman MA; Waring AJ
    Biochim Biophys Acta; 2002 Feb; 1559(2):96-120. PubMed ID: 11853678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure and orientation study of fusion peptide FP23 of gp41 from HIV-1 alone or inserted into various lipid membrane models (mono-, bi- and multibi-layers) by FT-IR spectroscopies and Brewster angle microscopy.
    Castano S; Desbat B
    Biochim Biophys Acta; 2005 Sep; 1715(2):81-95. PubMed ID: 16126160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphism and interactions of a viral fusion peptide in a compressed lipid monolayer.
    Schwarz G; Taylor SE
    Biophys J; 1999 Jun; 76(6):3167-75. PubMed ID: 10354441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of membrane activity from mutational analysis of the HIV fusion peptide.
    Torres O; Bong D
    Biochemistry; 2011 Jun; 50(23):5195-207. PubMed ID: 21561063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane structure of the human immunodeficiency virus gp41 fusion peptide by molecular dynamics simulation. II. The glycine mutants.
    Wong TC
    Biochim Biophys Acta; 2003 Jan; 1609(1):45-54. PubMed ID: 12507757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biophysical investigations of GBV-C E1 peptides as potential inhibitors of HIV-1 fusion peptide.
    Sánchez-Martín MJ; Urbán P; Pujol M; Haro I; Alsina MA; Busquets MA
    Chemphyschem; 2011 Oct; 12(15):2816-22. PubMed ID: 21905195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane structure of the human immunodeficiency virus gp41 fusion domain by molecular dynamics simulation.
    Kamath S; Wong TC
    Biophys J; 2002 Jul; 83(1):135-43. PubMed ID: 12080106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The amino-terminal peptide of HIV-1 gp41 interacts with human serum albumin.
    Gordon LM; Curtain CC; McCloyn V; Kirkpatrick A; Mobley PW; Waring AJ
    AIDS Res Hum Retroviruses; 1993 Nov; 9(11):1145-56. PubMed ID: 8312056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single mutation effects on conformational change and membrane deformation of influenza hemagglutinin fusion peptides.
    Li J; Das P; Zhou R
    J Phys Chem B; 2010 Jul; 114(26):8799-806. PubMed ID: 20552971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane-induced conformational change during the activation of HIV-1 gp41.
    Kliger Y; Peisajovich SG; Blumenthal R; Shai Y
    J Mol Biol; 2000 Aug; 301(4):905-14. PubMed ID: 10966795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.